Camurus ABCAMRF -3.57%79 Days Inventory is 281.25 as of Mar. 2026, which is 24% below its 10-year median of 368.67. GuruFocus rates CAMRF with a GF Score™ of 79/100 and a GF Value™ of $83.22 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 640 Biotechnology companies, Camurus AB ranks worse than 66.41% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Camurus AB's Average Total Inventories for the
three
months ended in Mar. 2026 was $12.3 Mil. Camurus AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $4.0 Mil.
Hence, Camurus AB's Days Inventory for the
three
months ended in Mar. 2026 was 281.25.
The historical rank and industry rank for Camurus AB's Days Inventory or its related term are showing as below:
CAMRF'
s Days Inventory Range Over the Past 10 Years
Min: 290.13 Med: 368.67 Max: 2144.38
Current: 290.13
During the past 13 years, Camurus AB's highest Days Inventory was 2144.38. The lowest was 290.13. And the median was 368.67.
CAMRF's Days Inventory is ranked worse than 66.41% of 640
companies
in the Biotechnology industry
Industry Median: 184.145
vs CAMRF: 290.13
Camurus AB's Days Inventory
declined
from Mar. 2025 (306.15) to Mar. 2026 (281.25).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Camurus AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.32.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Camurus AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.21.
Camurus AB (OTCPK:CAMRF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Camurus AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Camurus AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Camurus AB Days Inventory Related Terms
Camurus AB Days Inventory Historical Data
* Premium members only.
The historical data trend for Camurus AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAMRF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Camurus AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Camurus AB Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Camurus AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where Camurus AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Camurus AB (CAMRF) has a Days Inventory of 281.25 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Camurus AB and its competitors. This is 24% below median its historical median of 368.67. Over the past decade, Camurus AB's Days Inventory has ranged from 290.13 to 2,144.38. According to the industry distribution chart, Camurus AB ranks #425 out of 640 companies in the Biotechnology industry, placing it in the top 66.4%.
Is Camurus AB's Days Inventory too high?
Camurus AB's current Days Inventory of 281.25 is 24% below median its 10-year median of 368.67. Over the past 10 years, this metric has ranged from a low of 290.13 to a high of 2,144.38. The Biotechnology industry median Days Inventory is 184.15. Camurus AB's value of 281.25 is 52.7% above this industry median. Based on the distribution chart, Camurus AB ranks #425 out of 640 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Camurus AB has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Camurus AB's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Camurus AB ranks #425 out of 640 companies for Days Inventory. This places Camurus AB in the lower half of its industry. The industry median Days Inventory is 184.15. Camurus AB's value of 281.25 is 52.7% above this benchmark. Historically, Camurus AB's own Days Inventory has ranged from 290.13 to 2,144.38 over the past decade. While the company's 10-year median is 368.67 vs. the industry median of 184.15, Camurus AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 184.15, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Camurus AB's current Days Inventory of 281.25 is 52.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Camurus AB and its competitors. For the Biotechnology industry, the median Days Inventory is 184.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Camurus AB's current Days Inventory is 281.25, which is 24% below median its own 10-year median of 368.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camurus AB stock overvalued right now?
Based on GuruFocus' analysis, Camurus AB (CAMRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $83.22, compared to a current price of $54.00 — trading 35.1% below its estimated fair value. The current Days Inventory is 281.25, which is 24% below median its 10-year median of 368.67 and 52.7% above the Biotechnology industry median of 184.15. Camurus AB's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Camurus AB (CAMRF), the current Days Inventory is 281.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Camurus AB (CAMRF) Overvalued in 2026?
Based on GuruFocus' analysis, Camurus AB stock appears to be undervalued.
The current stock price of $54.00 is trading 35.1% below its estimated GF Value™ of $83.22.
GuruFocus considers Camurus AB to be Significantly Undervalued.
Key valuation signals for CAMRF:
Days Inventory: 281.25 (24% below median its 10-year median of 368.67)
GF Value™: $83.22 vs. price of $54.00 (35.1% below fair value)
Industry Position: 52.7% above the Biotechnology median (#425 of 640)
No single metric tells the full story. See the CAMRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Camurus AB is a science-led biopharmaceutical company focused on developing and commercializing long-acting medicines for the treatment of severe and chronic diseases. It has two approved products, including treatments for opioid dependence, and a development pipeline supported by its FluidCrystal technology. Its clinical pipeline includes product candidates for conditions such as pain, cancer, endocrine, and metabolic diseases, developed in-house and in collaboration with international pharmaceutical companies. Its pipeline programs include CAM2029 for acromegaly, gastroenteropancreatic neuroendocrine tumors, and polycystic liver disease; CAM2038 for chronic pain; CAM4072 for genetic obesity disorders; CAM2043 for Raynaud's phenomenon; CAM4071 for endocrine disorders, among others.
79GF Score
Get the complete analysis for CAMRF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAMRF has been successfully added to your 
